Verastem Inc (VSTM)
9.19
-0.12
(-1.29%)
USD |
NASDAQ |
Apr 25, 16:00
9.20
+0.01
(+0.11%)
After-Hours: 20:00
Verastem Cash from Financing (TTM): 134.19M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 134.19M |
September 30, 2023 | 134.64M |
June 30, 2023 | 161.16M |
March 31, 2023 | 70.38M |
December 31, 2022 | 51.78M |
September 30, 2022 | 58.59M |
June 30, 2022 | 33.13M |
March 31, 2022 | 32.92M |
December 31, 2021 | 6.885M |
September 30, 2021 | -36.53M |
June 30, 2021 | -36.56M |
March 31, 2021 | -24.37M |
December 31, 2020 | 69.63M |
September 30, 2020 | 93.53M |
June 30, 2020 | 93.89M |
March 31, 2020 | 90.90M |
December 31, 2019 | -2.441M |
September 30, 2019 | 155.73M |
June 30, 2019 | 155.31M |
March 31, 2019 | 260.94M |
December 31, 2018 | 261.16M |
September 30, 2018 | 162.42M |
June 30, 2018 | 176.56M |
March 31, 2018 | 61.10M |
December 31, 2017 | 63.18M |
Date | Value |
---|---|
September 30, 2017 | 16.46M |
June 30, 2017 | 2.248M |
March 31, 2017 | 2.386M |
December 31, 2016 | -0.005M |
September 30, 2016 | 0.046M |
June 30, 2016 | 0.108M |
March 31, 2016 | 8.23M |
December 31, 2015 | 63.58M |
September 30, 2015 | 73.05M |
June 30, 2015 | 72.79M |
March 31, 2015 | 64.61M |
December 31, 2014 | 8.774M |
September 30, 2014 | -0.743M |
June 30, 2014 | 58.74M |
March 31, 2014 | 58.77M |
December 31, 2013 | 58.49M |
September 30, 2013 | 58.49M |
June 30, 2013 | -0.796M |
March 31, 2013 | -0.762M |
December 31, 2012 | 57.60M |
September 30, 2012 | 77.09M |
June 30, 2012 | 108.99M |
March 31, 2012 | 121.06M |
December 31, 2011 | 63.46M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-36.56M
Minimum
Jun 2021
161.16M
Maximum
Jun 2023
65.41M
Average
69.63M
Median
Dec 2020
Cash from Financing (TTM) Benchmarks
Johnson & Johnson | -15.82B |
Geron Corp | 362.02M |
Altimmune Inc | 86.10M |
Oragenics Inc | 0.2839M |
Actinium Pharmaceuticals Inc | 14.87M |